Clinical Trial Update: Naltrexone in the Treatment of Dissociative Symptoms in Patients With Borderline Personality Disorder [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update reports completion of a study evaluating naltrexone for dissociative symptoms in Borderline Personality Disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Borderline Personality Disorder
• Dissociation

Drugs mentioned

• Naltrexone (Naltrexone)

Snippet

Sponsor: Central Institute of Mental Health, Mannheim | Conditions: Borderline Personality Disorder, Dissociation | Phase 2 | Status: COMPLETED